深部静脉疾病治疗设备市场：按类型、最终用户划分 - 全球预测 2025-2030

2023年深部静脉疾病治疗设备市场价值为10.9亿美元，预计到2024年将达到11.7亿美元，复合年增长率为7.64%，到2030年将达到18.3亿美元。

深部静脉疾病（DVD）治疗设备包括旨在诊断和治疗影响深部静脉系统的疾病的各种医疗设备和技术，例如深层静脉栓塞症（DVT）和慢性静脉功能不全（CVI）。久坐生活方式的增加、人口老化以及心血管疾病的增加（增加静脉疾病的风险）推动了对这些设备的需求。治疗范围包括医院、专科诊所和家庭保健，强调个别化治疗方法的重要性。最终使用者包括医疗保健提供者、医疗专业人员和寻求微创治疗解决方案的患者。影响市场的关键成长要素是设备技术的进步、早期诊断意识的提高以及对非侵入性治疗方案的需求。新治疗方法的出现和有利的监管环境为创新和成长提供了潜在的机会。市场参与企业可以探索策略联盟并投资于研发，以开发下一代静脉注射设备，以提高疗效和患者治疗效果。然而，高昂的治疗成本、严格的监管要求以及缺乏熟练专业人员等挑战可能会阻碍市场扩张。发展中地区的经济限制进一步抑制了成长潜力。为了缓解这些挑战，公司可以专注于具有成本效益的产品开发和加强专业培训的教育计划。创新成熟的领域包括穿戴式监测设备、人工智慧辅助诊断和生物整合治疗解决方案，以促进更快、更全面的復原过程。主要研究工作可以集中在了解 DVD 的分子机制和增强当前设备的生物相容性和功能。市场格局竞争激烈且充满活力，其特点是技术快速进步和不断变化的医疗保健需求，要求市场参与者在利用新机会的同时保持敏捷性和主动性。

市场动态：快速发展的深部静脉疾病治疗设备市场的关键市场洞察

供需的动态交互作用正在改变深部静脉疾病治疗设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

• 市场驱动因素
  • 深部静脉疾病在全球呈上升趋势
  • 提高预防设备意识
• 市场限制因素
  • 替代治疗方案的可用性
• 市场机会
  • 深部静脉疾病治疗设备的持续研发活动
  • 个体化血管帐篷及间歇式气动加压装置的研发
• 市场挑战
  • 缺乏熟练的专业人员

波特五力：开拓深部静脉疾病治疗设备市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解深部静脉疾病治疗设备市场的外部影响

外部宏观环境因素在塑造深部静脉疾病治疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解深部静脉注射疾病治疗器材市场的竞争状况

深部静脉疾病治疗设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵深部静脉疾病治疗设备市场供应商的绩效评估

FPNV 定位矩阵是评估深部静脉疾病治疗设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划深部静脉疾病治疗设备市场的成功之路

对于希望加强在全球市场的影响力的公司来说，对深部静脉疾病治疗设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 全球深部静脉疾病发生率增加
    • 提高对预防设备的认识
  • 抑制因素
    • 替代治疗方案的可用性
  • 机会
    • 深部静脉疾病治疗设备的持续研发活动
    • 个性化血管帐篷和间歇式气动加压装置的开发
  • 任务
    • 缺乏熟练的专业人员
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章深部静脉疾病治疗设备市场：依类型

• 压缩装置
• 週边血管支架
• 血栓切除和溶栓装置

第七章深部静脉疾病治疗设备市场：依最终使用者分类

• 门诊手术中心
• 医院/诊所

第八章北美和南美深部静脉疾病治疗设备市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太地区深部静脉疾病治疗器材市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章欧洲、中东和非洲的深部静脉疾病治疗设备市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• Abbott Laboratories
• Acandis GmbH
• Alma Lasers GMBH
• Andratec GmbH
• AngioDynamics, Inc.
• Becton, Dickinson, and Company
• Biolitec AG
• Boston Scientific Corporation
• Cardinal Health
• Imperative Care
• Innova Vascular, Inc.
• Johnson & Johnson Medical NV
• Kavya Pharma
• Koninklijke Philips NV
• Medtronic PLC
• Merit Medical Systems, Inc.
• Nipro Corporation
• Penumbra Inc.
• Stryker Corporation
• Surmodics, Inc.
• Teleflex Incorporated
• Terumo Corporation

The Deep Venous Disease Treatment Devices Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 1.83 billion by 2030.

Deep Venous Disease (DVD) Treatment Devices encompass a range of medical devices and technologies aimed at diagnosing and treating conditions affecting the deep venous system, including deep vein thrombosis (DVT) and chronic venous insufficiency (CVI). The necessity for these devices is driven by the increasing prevalence of sedentary lifestyles, aging populations, and rising incidences of cardiovascular diseases, which heighten the risk for venous disorders. Applications extend to hospitals, specialty clinics, and home healthcare settings, emphasizing the importance of tailored treatment approaches. End-users include healthcare providers, medical professionals, and patients seeking minimally invasive therapeutic solutions. Significant growth factors influencing the market are advancements in device technology, growing awareness on early diagnosis, and the demand for non-invasive treatment options. The emergence of novel therapies and favorable regulatory landscapes present potential opportunities for innovation and growth. Market participants can explore strategic collaborations and invest in R&D to develop next-generation venous devices that enhance efficacy and patient outcomes. However, challenges such as high treatment costs, stringent regulatory requirements, and the dearth of skilled professionals may pose hurdles to market expansion. Economic constraints in developing regions further impede growth potential. To mitigate these challenges, companies could focus on cost-effective product development and educational programs to bolster professional training. Areas ripe for innovation include wearable monitoring devices, artificial intelligence-assisted diagnostics, and biologically integrated treatment solutions that promote faster and more holistic healing processes. Key research efforts can pivot towards understanding the molecular mechanisms of DVD and enhancing current device biocompatibility and function. The market landscape is competitive and dynamic, characterized by rapid technological advancements and evolving healthcare demands, mandating market players to stay agile and forward-thinking to maintain a competitive edge while tapping into emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deep Venous Disease Treatment Devices Market

The Deep Venous Disease Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of deep vein diseases across the world
  • Rising awareness about preventative devices
• Market Restraints
  • Availability of alternative treatment options
• Market Opportunities
  • Ongoing research and development activities for deep vein disease devices
  • Development of personalized vascular tents and intermittent pneumatic compression devices
• Market Challenges
  • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Deep Venous Disease Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deep Venous Disease Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deep Venous Disease Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deep Venous Disease Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deep Venous Disease Treatment Devices Market

A detailed market share analysis in the Deep Venous Disease Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deep Venous Disease Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deep Venous Disease Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deep Venous Disease Treatment Devices Market

A strategic analysis of the Deep Venous Disease Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deep Venous Disease Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Alma Lasers GMBH, Andratec GmbH, AngioDynamics, Inc., Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Cardinal Health, Imperative Care, Innova Vascular, Inc., Johnson & Johnson Medical NV, Kavya Pharma, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra Inc., Stryker Corporation, Surmodics, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Deep Venous Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Compression Device, Peripheral Vascular Stent, and Thrombectomy & Thrombolysis Device.
• Based on End User, market is studied across Ambulatory Surgical Centres and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of deep vein diseases across the world
    • 5.1.1.2. Rising awareness about preventative devices
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative treatment options
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities for deep vein disease devices
    • 5.1.3.2. Development of personalized vascular tents and intermittent pneumatic compression devices
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Deep Venous Disease Treatment Devices Market, by Type

• 6.1. Introduction
• 6.2. Compression Device
• 6.3. Peripheral Vascular Stent
• 6.4. Thrombectomy & Thrombolysis Device

7. Deep Venous Disease Treatment Devices Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centres
• 7.3. Hospitals & Clinics

8. Americas Deep Venous Disease Treatment Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Deep Venous Disease Treatment Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Deep Venous Disease Treatment Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. Alma Lasers GMBH
• 4. Andratec GmbH
• 5. AngioDynamics, Inc.
• 6. Becton, Dickinson, and Company
• 7. Biolitec AG
• 8. Boston Scientific Corporation
• 9. Cardinal Health
• 10. Imperative Care
• 11. Innova Vascular, Inc.
• 12. Johnson & Johnson Medical NV
• 13. Kavya Pharma
• 14. Koninklijke Philips N.V.
• 15. Medtronic PLC
• 16. Merit Medical Systems, Inc.
• 17. Nipro Corporation
• 18. Penumbra Inc.
• 19. Stryker Corporation
• 20. Surmodics, Inc.
• 21. Teleflex Incorporated
• 22. Terumo Corporation

LIST OF FIGURES

• FIGURE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COMPRESSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY THROMBECTOMY & THROMBOLYSIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023